Vaxart, Inc. Skyrocketed
Mon, May 15, 2023 at 07:43 PM
Vaxart, Inc. (VXRT:NASDAQ) rocketted at $1.37, a gain of 30.5%. On Mon, May 15, 2023, VXRT:NASDAQ touched a New 2-Week High of $1.37. The stock appeared on our News Catalysts scanner on Thu, May 04, 2023 at 05:03 PM in the 'INVESTOR UPDATE' category. From Mon, May 01, 2023, the stock recorded 80.00% Up Days and 72.73% Green Days
About Vaxart, Inc. (VXRT:NASDAQ)
Aviragen Therapeutics Inc is a bio-pharmaceutical company. It is engaged in developing direct-acting antivirals to treat infections that affect a number of patients. It includes oral, small molecule compounds to treat infectious diseases.
Top 10 Gainers:
- NeoGames S.A. (NGMS:NASDAQ), 111.6%
- Ohmyhome Limited (OMH:NASDAQ), 67.28%
- Getaround Inc. (GETR:NYSE), 41.64%
- ImmunityBio Inc. (IBRX:NASDAQ), 41.23%
- MGO Global Inc. (MGOL:NASDAQ), 31.09%
- Sarepta Therapeutics, Inc. (SRPT:NASDAQ), 30.77%
- Vaxart, Inc. (VXRT:NASDAQ), 30.48%
- Eastside Distilling, Inc. (EAST:NASDAQ), 28.72%
- TuSimple Holdings Inc. (TSP:NASDAQ), 28.03%
- Inpixon (INPX:NASDAQ), 27.75%